Drug Precursors: Initial Appraisal of the Commission's Impact Assessment

Briefing 15-03-2013

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposal for a Regulation on drug precursors. Drug precursors are chemical substances that may be produced for licit purposes, but which can be misused for illegal drug production. A specific regulatory framework has been set up both at international level and within the EU to prevent the diversion of drug precursors to illicit drug production.